Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Anemia Drugs Companies

ID: MRFR/Pharma/1859-HCR
84 Pages
Vikita Thakur
Last Updated: February 16, 2025
Several pharmaceutical companies were actively involved in the development, manufacturing, and distribution of drugs for the treatment of anemia. Anemia is a condition characterized by a deficiency of red blood cells or hemoglobin, leading to reduced oxygen-carrying capacity in the blood. 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anemia Drugs Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.22%
2024 Market Size$ 8.24 Billion
2025 Market Size$ 8.85 Billion
2035 Market Size$ 16.07 Billion
Key Players
Amgen
Roche
Novartis
Bristol-Myers Squibb
Pfizer
Sanofi
Opportunities
  • Aging Population
  • Market Growth Projections
  • Rising Prevalence of Anemia

Top Industry Leaders in the Anemia Drugs Market

Anemia Drugs Companies
Latestย Anemia Drugsย Companies Update:

InSilico Medicine announced a breakthrough AI-driven discovery of a novel PHD inhibitor for anemia treatment. This potentially offers a new approach to targeting the underlying cause of anemia, particularly in cases where existing medications aren't effective. (October 26, 2023)

GSK's Jesduvroq (daprodustat) continues to gain traction as a novel anemia treatment for kidney disease patients. Approved in February 2023, this drug offers an alternative to erythropoiesis-stimulating agents (ESAs) and is already seeing adoption in some markets. (November 7, 2023)

No major M&A deals involving major anemia drug companies have been announced recently. However, smaller players in the field are actively acquiring technologies and expanding their portfolios. For example, Cygnus Technologies' acquisition of SiNica Bio strengthens their presence in the Asian HCP testing market, which can indirectly impact anemia drug development.

List ofย Anemia Drugsย Key companies in the market
  • Amgen Incย 
  • GlaxoSmithKline plcย 
  • Bluebird bioย 
  • Bioconย 
  • GlycoMimetics Incย 
  • Regen biopharma Incย 
  • Bayer AGย 
  • Acceleron Pharmaย 
  • Eli Lilly and company
ย